FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Adjuvant therapy with a modified FOLFIRINOX regimen led to significantly longer survival than gemcitabine among patients with resected pancreatic cancer, at the expense of a hig...
Publications
View AllImproved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Dabrafenib plus trametinib, as compared with vemurafenib monotherapy, significantly improved overall survival in previously untreated patients with metastatic melanoma with BRAF...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- FR
- Publications
- 3
- Citations
- 5,602
External Links
Identifiers
- ROR
- https://ror.org/01jbb3w63